Damascus-SANA
Medicine magazine published a case documented by the General Authority of Damascus Hospital in which it succeeded in treating a 13-year-old child suffering from severe ulcerative colitis through a biological treatment usually used for adults.
Regarding the details of the case, which were published in issue 38 of the magazine, the director of the hospital and supervisor of the case, Dr. Ahmed Abbas, explained that the child was referred to the hospital with symptoms of abdominal pain, severe diarrhea accompanied by blood, poor general condition, high fever, severe flatulence in the abdomen and lack of growth, and he did not respond to the traditional treatments used in these cases.
Dr. Abbas indicated that the option after the failure of the treatment was to remove the entire colon because the condition was developing and threatening the child's life, which prompted the decision to apply a biological treatment (golimumab), which is used to manage adults in order to save the child and improve the quality of his life.
The director of the hospital stated that the child responded to the treatment since the first dose that was given to him a year ago, and he did not have any complications, which prompted the hospital to document them, indicating that the child is still undergoing doses so far, because ulcerative colitis is a chronic disease.
Dr. Abbas pointed out that the hospital applied this treatment after its success on four other children, but it has not yet documented the cases.
It is noteworthy that the British Oxford magazine documented and published last year a rare scientific case diagnosed in the General Authority of Damascus Hospital of a girl suffering from (Thefinard Syndrome), a rare genetic disease that has been recorded in only a few cases in the medical literature and usually ends with self-amputation of the limbs.
Rama Rashidi